Cholesterol control agent

Abstract

The invention relates to medicine and can be used for producing a medicinal agent for normalising the cholesterol level. The aim of the invention is to develop a physiologically acceptable cholesterol-control agent which is nontoxic and does not cause addiction of organism. In preferred embodiments, the method for producing said agent consists in using 2-6 weight parts of a 36.5-40.0% formaldehyde medicinal solution and in adding 998-994 weight parts of a sterile 0.85-0.95% sodium chloride solution which is used for injection in such a way as to produce a 0.07-024% formaldehyde solution. The agent is stored at a temperature of 15-35° C. It also encompasses a method for treatment of patients for lowering their cholesterol levels that comprises administering the agent to the patients as intramuscular injections with a predetermined dose at a predetermined time interval.

1 . A preparation, possessing cholesterol-lowering action, consisting essentially of:
 an active substance in the form of an aqueous solution of formaldehyde with a concentration of 36.5-40%, said active substance constitutes from 2 to 6 weight units; and   an additive in the form of an isotonic solution of sodium chloride with a concentration of 0.85-0.95%, said additive constitutes from 998 to 994 weight units accordingly, to make the total of 1000 weight units.   
   
   
       2 . A method for obtaining a preparation comprising the steps of:
 providing an aqueous solution of formaldehyde with a concentration of 36.5-40% in the amount of from 2 to 6 weight units;   providing an isotonic solution of sodium chloride with a concentration of 0.85-0.95% in the amount of from 998 to 994 weight units; and   adding said aqueous solution into said isotonic solution thereby obtaining said preparation.   
   
   
       3 . The method of  claim 2 , further comprising the step of storing said preparation in a dark place at temperature of 15-35° C. 
   
   
       4 . A method for treatment of patients for lowering their cholesterol levels comprising:
 administering the preparation of  claim 1  to the patients as intramuscular injections with a predetermined dose at a predetermined time interval.   
   
   
       5 . The method of  claim 4 , wherein said predetermined dose constitutes 5 mL. 
   
   
       6 . The method of  claim 4 , wherein said predetermined time interval is selected from the group consisting of 7, 21, 30, and 60-day intervals.